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In today’s world, there is an urgent need to discover novel antibiotics due to the 
rise of antibiotic resistance and the lack of new ones being approved.  Building off of 
Hanson et al. and their reduction-oxidation sensitive green fluorescent protein 
(roGFP)(1), that we yeast codon optimized (2); I wanted to determine if I could create a 
real-time biosensor that has the ability to respond to ROS produced in the stress response 
triggered by antibiotics as a platform to identify novel antibiotics.  To achieve this, I need 
to know if it will oligomerize in bacterial cytoplasm due to its two cysteines at 48 and 70 
and what the optimal conditions are for the biosensor.  From western blot results, royGFP 
does not oligomerize in the cells showing that our biosensor should not lose fluorescence.  
royGFP had a strong sensitivity to hydrogen peroxide and ROS triggered from 
antibiotics. The results showed that royGFP can be used as an ROS biosensor tool to help 
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1.1 An Urgent Need to Find Novel Antibiotics 
Novel antibiotics need to be identified to combat the growing problem of 
antimicrobial resistance.  In today’s world, antibiotic resistance is on the rise, and we will 
soon be in a time similar to the early nineteenth century, where there were no medical 
therapies against bacterial infection (3).  Almost all antibiotics used today were 
discovered in the mid-twentieth century, as these are mostly natural products.  Resistance 
was already present in a small percentage of bacteria but was quickly enriched and 
widespread due to misuse and overuse of antibiotics (4).  Meanwhile, newer drugs are 
rarely used in order to try to decrease the risk of further resistance development, as they 
are based on older drugs that bacteria have already shown some resistance to.  The fact 
that fewer pharmacological companies are researching novel antibiotics exacerbates the 
problem (5).  It is paramount that new, advanced, and unique antibiotics are continued to 
be discovered to combat this rise in resistance.  
To combat this growing threat, my goal is to find new antibiotics.  This will 
accomplished by quantifying the stress response of cells to known antibiotics.  Cells can 
become easily stressed due to any number of factors such as toxic agents like antibiotics 
or a lack of nutrients and as a response, release massive amounts of reactive oxygen 
species (ROS)(6).  ROS molecules like superoxide anion, hydroxyl radicals, and 
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hydrogen peroxide are a natural byproduct of cell respiration and metabolism and are 
known physiological messengers but do accumulate during times of stress(7).  This stress 
response is strong when antibiotics are administered and can be used to determine the 
potential of an antibiotic’s efficacy.  Using roGFP from Hanson et al. (1), we can 
quantify the stress response by measuring the ROS triggered by the antibiotic stress.  
Furthermore, the presence of two natural cysteines allows GFP to oligomerize in 
response to ROS, a concern this research due to a loss in fluorescence.  
By the end of my research, I will have determined if oligomerization is a concern 
for the biosensor and will have made progress on discovering the optimal conditions for a 
system using a redox-sensitive GFP biosensor.  This biosensor will have the capability to 
identify a change in the oxidative environments and measure the stress response of E. coli 
based on a simple change in fluorescence.  
The GFP strains used in these experiments are yeast-enhanced GFP (yEGFP) and 
yeast-enhanced GFP fast folder (yEGFP FF).  Redox-sensitive yeast-enhanced GFP 
(royGFP) and redox-sensitive yeast-enhanced GFP fast folder (royGFP FF).  All are yeast 
codon optimized that give it 75 times more fluorescence in E. coli (2) and contain the 
enhanced mutations at F64L and S65T, while royGFP and royGFP FF contains two 
cysteine mutations at S147C and Q204C to turn it into a redox biosensor.  
1.2 Antibiotic Resistance 
Antibiotics are a natural substance or pharmacologically altered substance that 
hinders the growth of or kills a bacterium.  As a natural product, antibiotics originally 
evolved to reduce competition between eukaryotes and prokaryotes, as well as between 
bacterial species.  Growth inhibiting (static) and killing (cidal) are the two main 
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categories of antibiotics which act by inhibiting any of three main cell functions: DNA 
replication, protein synthesis, and cell wall construction (6).  Two examples of these 
categories are Kanamycin and Ampicillin.  Kanamycin binds to the 30s ribosomal 
subunit, acting as a bacteriostatic agent, inhibiting growth by creating mistranslated 
proteins.  Without the ability to make functional proteins for cell usage, the cell will 
slowly die due to a lack of functionality and growth.  Ampicillin hinders the synthesis of 
the peptidoglycan linkages in the cell wall causing bacteriolysis and cell death (4).   
Antibiotic resistance is the ability of a bacteria to resist or defend itself from a 
substance that kills or inhibits the growth of that bacteria.  The study of antibiotic 
resistance is as old as the use of antibiotics themselves (4), but it wasn’t until recently 
that we started realizing that bacterial resistance has the inevitable potential to spread 
faster than our present library of antibiotics creating a need to identify new classes of 
antibiotics.  Resistance, like any other genetic advantage, is mainly created through 
horizontal gene transfer and point mutations.  The causes of these point mutations come 
mostly from replication errors and mutagens in the environment.  With a high enough 
population, millions of individual cells creating mutations greatly increases the 
possibility of a new antibiotic resistance gene.  Once the resistance gene is in the genome 
of one cell, bacteria have multiple ways of spreading the resistance gene.  If a population 
is being attacked by an antibiotic, the resistant cell will be unaffected and live on to 
produce more cells with the same mutation.  This is natural selection; the surviving 
unaffected population will be able to produce more offspring carrying this gene while all 
the non-resistant ones perish.  Bacteria can spread this gene to other bacteria through 
transformation, conjugation, and transduction.  In transformation, if a cell releases its 
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contents due to it being killed or other potential factors, its genetic material can be taken 
up from the environment by other living bacteria, who can integrate this gene into its own 
genome to gain its function through homologous recombination.  Conjugation is the 
process of sharing genes through sex pili on the bacteria’s surface.  And lastly, 
transduction is when genes are transferred virally.  All three of these processes allow 
other bacteria to use the resistant gene for its own genetic advantage (8).   
In the healthcare field, there are two main problems that are responsible for 
increasing antibiotic resistance.  The first problem is that most antibiotic treatments are 
prescribed for a short period of time because it only takes a few weeks to rid the body of 
a bacterial infection.  This is in contrast to other chronic illnesses such as Parkinson’s that 
take years of medication to cure or just ease the symptoms.  This trend in medicine really 
limits the amount of antibiotics sold, lowering profit margins.  The second reason is more 
indirect; newer antibiotics are not used unless for a more serious case to prevent acquired 
resistance.  This lowers the market demand for new antibiotics since profit cannot be 
made up front (9).  Contributing to this issue is the influx of generic competitors, whose 
drugs not only reduce profit margins because they can be sold for less but flood the 
market helping create this natural selective pressure for resistance.  Large pharmaceutical 
companies only allocate about 1.6% of its resources to developing new antibiotics (4).  
The effect of these patterns has already begun to show itself in hospitals.  Methicillin-
resistant Staphylococcus aureus (MRSA) has been killing on average 19,000 people a 
year in the US and adding about 3 billion dollars’ worth to healthcare cost.  The rise of 
resistant strains slowly spread, creating even worse strains such as a vancomycin-resistant 
strain that will most likely wreak havoc in the near future (9)(10).   
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1.2.1 Reactive Oxygen Species 
Bacteria, like all other cellular organisms produce and use reactive oxygen species 
(ROS).  ROS are compounds such as hydrogen peroxide, hydroxyl radicals, and 
superoxide anion.  They all contain oxygen and are natural by-products of an organism’s 
metabolism and aerobic respiration.  ROS has been shown to be an essential 
physiological messenger in cellular systems such as cancer, stem cells, and the immune 
system (7), but can cause damage to DNA, lipids, and proteins when accumulated 
(11)(12).  Most cells have an organelle or an enzyme that can pump out ROS or 
chemically convert it to a safer substance, such as catalase that converts hydrogen 
peroxide to water and oxygen gas.  In addition to their specific biological targets, 
members of the three major classes of antibiotics indirectly harm the cell by triggering 
the production lethal amounts of ROS, mainly hydroxyl radicals.  The large amounts of 
hydroxyl radicals come from a metabolic deficit leading to the oxidation of iron-sulfur 
clusters, called the Fenton reaction, that triggers the release of these hydroxyl ions that 
work like a wrecking ball in the cell damaging all types of cellular structures (6)(7).   
1.3 Green Fluorescent Protein 
Green fluorescent protein (GFP) is a bioluminescent protein that was discovered 
in the jellyfish Aequorea victoria by Shimomura et al. in 1962 (11).  The protein becomes 
bioluminescent by absorbing blue light at 470 nm created by the protein aequorin and 
emits green light at the 508 nm wavelength in the jellyfish (14).  GFP consists of 238 
amino acids long and is fairly stable and resistant to photobleaching and a wide range of 
environments due to its beta barrel structure, which is composed of 11 beta strands with 6 
alpha helixes (15).  The chromophore sits in the middle of the beta barrel and consists of 
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amino acids serine at 65, tyrosine at 66, and glycine at 67 (13).  These amino acids 
together form a p-hydroxybenzylidene-imidazolidinone structure that requires oxygen to 
become fluorescent.  Due to this, GFP cannot be used in anaerobic organisms, limiting its 
range of research (16). 
1.3.1 GFP Beginnings 
From the beginning, GFP showed real promise as a local reporter protein and as a 
fusion tag in cells due to how easily it can be transformed and its ability to be tracked in 
real-time with long wave UV light source and not needing a cofactor to be fluorescent 
(17)(13).  Before more in-depth research could be done with GFP, it needed some 
improvements to be a better molecular tool.  GFP being from a cold-water jellyfish of the 
north Pacific Ocean, does not fold well  or fluoresce at warmer temperatures like 37°C 
(13).  To improve this, mutations were made to and around the chromophore that 
consisted of serine to threonine at 65 and phenylalanine to leucine at position 64.  These 
mutations allow for better protein synthesis, folding efficiency, and a 30-fold increase in 
brightness.  This new version of GFP was termed enhanced GFP, EGFP, and acts very 
similar to the wildtype GFP but its excitation changed from two peaks to only one 
maximum peak at 488 nm (18).  EGFP’s mutations had such an improvement that it is 
used as the basis for almost every type of GFP research today (19)(20)(21).  Dr. 
Hindmarsh’s lab has plans to use this EGFP in the yeast Candida albicans, as well.  C. 
albicans belongs to a group referred to as the CTG clade.  For the codon CTG, most 
species encode leucine while C. albicans encodes serine instead.  To further expand 
GFP’s capabilities, it was enhanced for yeast cells and other singled celled organisms 
such as E. coli where the yeast enhancement mutations work very well.  EGFP was 
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optimized for C. albicans by replacing all CTG codons for a different leucine codon and 
replacing a few other amino acids to optimize the coding sequence for C. albicans.  
When transformed into E. coli, there is 75x more fluorescence in these cells than in the 
original wild type GFP cells (2). 
1.3.2 GFP Color Variations 
Utilizing the color of proteins has high potential for research purposes.  With only 
one or two amino acid mutations, GFP has the ability to fluoresce at multiple colors.  
Useful research color variants that have be used so far are blue, cyan, and yellow (22).  
They are used together to track multiple targets at once and each color mutation comes 
with its own special abilities.  Mutating glutamic acid at position 69 to lysine (E69K) and 
threonine to tyrosine at position 203 (T203Y) changes the fluorescence yellow.  Yellow 
fluorescent proteins are best at withstanding extreme temperatures and have the ability to 
refold after denaturing temperature exposure (23).  Mutating tyrosine to tryptophan at 
position 66 (Y66W) changes the green to a cyan color.  Cyan fluorescent proteins are 
good at withstanding wide pH ranges (13)(15).  Another useful color mutation is tyrosine 
to histidine at position 66 (Y66H) creating a blue color.  Blue fluorescent proteins are 
mainly used in tandem with GFP to track multiple proteins at once (13).  Of the color 
mutants, blue tends to photo bleach and fold more poorly than the rest (24).   
1.3.3 Problems with GFP 
As discussed earlier, ROS are essential to some physiological processes but can 
be harmful in cells if it accumulates and can cause damage to DNA, lipid, and 
membranes (7).  EGFP creates one hydrogen peroxide molecule as the chromophore 
matures to fluorescence using an oxygen molecule.  While this process does not create 
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enough hydrogen peroxide to be dangerous to the cell, it is enough to act as a cellular 
messenger.  This has the ability to alter research results in and can have severe 
consequences in many mammalian cells by causing random signals to come and go 
changing metabolism, stress response, or homeostasis (11).  
1.3.4 Oligomerization of GFP 
As widely used as GFP is, in certain environments it is not an optimal fluorescent 
reporter protein.  GFP suffers in oxidative environments like the endoplasmic reticulum, 
an organelle of eukaryotic organisms, where it does not fold properly or fluoresce due to 
oligomerization and pH sensitivity (19)(20)(25).  Oligomerization occurs through 
disulfide bridges across GFP’s two naturally occurring cysteines at positions 48 and 70 
(21), causing GFP to be secreted from the cell as a dimer (25), rendering it an ineffective 
tool.   Jain et al. (2006) researched this issue and showed that by substituting the 
cysteines with serine, a similarly structured amino acid, the folding ability was restored 
but the fluorescence was reduced (19).  Another way this issue was overcome was by 
creating two new variants of GFP, “fast folder” (FF) and “superfolder” (SF) (26).  The 
fast folder and superfolder GFP were created by starting off with the EGFP mutations, 
F64L and S65T, then adding the cycle 3 mutations, F99S, M153T, and V163A, and 
lastly, mutating, Y39N, N105T, Y145F, and I171V to make the fast folder variant and 
adding S30R and A206V to the fast folder to make the superfolder variant.  The addition 
of all of these mutations improved the folding ability of GFP by 50-fold.  Fast folder and 
superfolder GFP have been shown to be a reliable and useful tool in research for 
biosensing and monitoring with fusion proteins and in oxidative environments such as the 
endoplasmic reticulum (26).  These GFP variants fold quickly enough that dimers and 
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oligomers do not form, allowing for it to remain effective and fluorescent (20) and allows 
for the molecular trafficking through the pH-varied organelles of eukaryotes (25).  These 
fluorescent proteins maintain their fluorescence and are much brighter than only 
substituting the cysteines out (21).  
1.4 Biosensor Capabilities 
Green fluorescent protein has many capabilities and has progressively become 
one of the most used fluorescent proteins for research.  One of these discovered functions 
is as a biosensor.  A biosensor is a biological molecule that is used to detect chemicals or 
changes in the environment.  A GFP biosensor changes its fluorescence in the presence of 
a substance or molecule.  GFP has already been used successfully to detect redox 
reactions (26), calcium ions (27), and reactive oxygen species (1).  To determine the 
redox potential of the environment, Hanson et al. mutated GFP at specific points along 
the beta barrel around the chromophore.  These positions, 147/204 and 149/202, were 
substituted for cysteine, an amino acid that has a thiol group allowing for a disulfide 
linkage to form.  The paired amino acids are in close proximity to each other to allow 
formation of a disulfide bridge.  The presence of ROS creates an oxidizing environment, 
which in turn, forms the disulfide bond between them putting strain on the chromophore 
and changing its excitation spectra.  The change in fluorescence can be measured and 
correlated to the amount of ROS generated in the cell.  To keep the biosensor from 
making mistaken linkages, the two natural cysteines were substituted for serine at 48 and 
alanine at 70 to hinder any false readings.  They concluded that the 147/204 mutant GFP 







2.1 Creation of yEGFP, royGFP and Fast Folder variants 
The two main GFP strains used in this research was yeast-enhanced GFP, yEGFP, 
and redox-sensitive yeast-enhanced GFP, royGFP.  yEGFP and royGFP were both 
created in Dr. Hindmarsh’s lab using Quik-Change Mutagenesis by Claire Jones.  Both 
strains contain the yeast codon optimization because yeast are a part of the CTG clade, 
where CTG codes for serine instead of leucine and requires optimization of non-yeast 
proteins to function properly in its cells. These mutations make GFP 75x brighter when 
transformed into E. coli cells (2). The plasmids also contain enhanced mutations, F64L 
and S65T.  These mutations are critical because GFP is from a cold-water jellyfish and 
they allow for GFP to fold and fluoresce better at higher temperatures like 37°C.  royGFP 
contains two substituted cysteines at positions 147 and 204 that allow it to be a biosensor, 
yEGFP does not contain these mutations.   
yEGFP and royGFP fast folder variants were made in Dr. Hindmarsh’s lab by 
Doug Ferrell.  They were created from Ms. Jones’ strains and were Quik-Changed with 
the mutations F99S, M153T, V163A, which are called the cycle-3 mutations.  The fast 
folders also contain Y39N, N105T, Y145F, and I171V.  The substitutions of these amino 
acids allow the proteins to fold much quicker and fluoresce brighter.  
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2.2 Western Blot of yEGFP 
To begin, an overnight culture of yEGFP was performed by adding 5 µL of 
Ampicillin and a colony from a TSA-Ampicillin plate to a 5 mL TSB tube.  The next day, 
200 µL of the overnight culture of yEGFP E. coli cells were pipetted into a 100 mL TSB 
flask along with 100 µL of Ampicillin.  The culture was incubated for 4-5 hours to reach 
an optical density of 0.85-0.95.  Four separate sterile tubes were filled with 6 mL of culture 
from the flask. A different concentration of hydrogen peroxide was added to each tube; 0 
µL, 40 µL, 160 µL, and 200 µL per milliliter of cells, equally 0, 8.7, 33.8 and 146.7 mM.  
The cells and hydrogen peroxide mix were then incubated for 4 hours at 37°C in an 
incubator/shaker.  After incubation, 3 mL were removed from each tube and spun down in 
a 1.5 mL Eppendorf tube for 5 minutes at 14,800 rpm and the supernatant were poured off.  
This sample was stored at -80C, if needed.  
A lysozyme buffer was created to lysis the cell wall to retrieve the GFPs from the 
cells.  The buffer consisted of 500 µL of 1M Tris 8.0 pH, 3 mL of 5M NaCl, 50 µL of 
200x lysozyme, 5 µL of 1M CaCl2, 50 µL of 1 M MgCl2, 10 µL of 0.1% Triton x100, 100 
µL of 100x phenylmethylsulphonyl fluoride (PMSF), a protease inhibitor, and 6.375 mL 
of distilled water.  The amount of lysis buffer was added based on the size of the pellet.  
Most experiments required 400 µL of lysis buffer for the tube with 0 µL hydrogen 
peroxide due to a larger pellet.  Tubes with 8.7 and 33.8 mM of hydrogen peroxide 
received 200 µL of lysis buffer for a medium sized pellet and the last tube, 146.7 mM of 
hydrogen peroxide, received 100 µL of lysis buffer due to the smaller pellet.  The PMSF 
and lysozyme was re-added for every repeated experiment attempted to make sure the 
lysozyme was not degraded for later uses.  The samples were incubated for 4 hours at 
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37°C.  The samples were then spun down at 14,800 rotations per minute (RPM) for 5 min 
creating a pellet and supernatant.  The supernatant is transferred to another tube to be 
tested in a western blot.  
The gel electrophoresis was setup in a vertical stand and filled with the running 
buffer.  15 µL of sample was mixed with 5 µL of dye in a 1.5 mL Eppendorf tube and 
then heated for 10 min at 95°C.  5 µL of dye was preloaded into the wells to make them 
more visible and have more dye for the sample.  The samples were added in order of 
increasing hydrogen peroxide concentration, such as 0, 8.7, 33.8, 146.7mM.  The gel 
electrophoresis was run and then soaked in reagent alcohol.  The transfer was set up with 
a thin sheet of paper and a foam pad that was laid on both sides of the gel and soaked in 
the excess alcohol.  The gel was then placed in the transfer mechanism facing the positive 
side.  The transfer was run overnight to get a full transfer to the PVDF membrane.  Next, 
the membrane was blocked with a milk/tween mixture.  It consisted of 10 mL of 5x TBS, 
40 mL of water, 50 µL of tween and 2.5 g of powdered milk.  The membrane was soaked 
in half the mixture for a one 1-hour segment and then refreshed the mixture for another 
hour of blocking.  Next, the membrane was probed with a tween mixture containing the 
GFP antibody.  It contained 10 mL of 5x TBS, 40 mL of water, 50 µL of tween, and 0.5 
µL of antibody.  The membrane was washed twice with half of the mixture each time to 
get full coverage.  Lastly, the membrane was washed with the same tween solution 
without any milk or antibody.  This allowed for the wash to remove any unbound 
antibodies except the antibody that is connected to the protein sample.  We then 
visualized the membrane using enhanced chemiluminescence (ECL).   
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2.3 Quik-Change Mutagenesis of royGFP Positions 48 and 70 
2.3.1 Quik-Change Mutagenesis 
Three different mutations were generated to determine if royGFP could maintain 
fluorescence with substitutions.  A polymerase chain reaction (PCR) was completed on 
royGFP plasmid cells to create the three different mutations.  Each PCR tube contained 
12.5 µL of water, 5.5 µL of Taq buffer, 5.5 µL of dNTPs, and 1 µL of the forward and 
reverse primers, and 2 µL of Taq polymerase.  The first reaction, N1, had the primers for 
a cysteine to methionine mutation (C48M) at position 48 on the GFP peptide chain.  
Reaction two, N2, was cysteine to valine (C48V) at position 48.  And lastly, N3, was 
cysteine to glutamine (C70Q) at position 70.  After the PCR reaction, it went through a 
Dpn1 digestion.  DNA extracted from cells have been methylated because Dpn1 digests 
the methylated template but does not digest the amplicon.  This was done by adding 1 µL 
of Dpn1 and was incubated overnight at 37°C.  120 µL of DH5α E. coli cells were put 
into three 1.5 mL Eppendorf tubes, one for each reaction.  5 µL of the Quik-Change 
reactions was added to an Eppendorf tube with the cells.  These tubes were then 
incubated for 30 minutes on ice and then switched to 42°C for 90 seconds.  900 µL of 
TSB was added to each tube and then were placed in an incubator/shaker for one hour at 
37°C.  After incubation, 185 µL of the sample was plated on a TSA-Ampicillin plate and 
incubated overnight.   
2.3.2 Colony PCR  
A colony PCR is performed to determine if the plasmid was transformed into the 
DH5α E. coli cells.  Colonies were picked from the plates with a toothpick and added to a 
1.5 mL Eppendorf tube with 20 µL of sterile water, which was used as the DNA template 
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for the colony PCR.  The toothpick was twirled and then streaked on a TSA-Ampicillin 
plate on a grid and then incubated overnight.  The plate was checked the next day to 
determine if the colonies grew and if they had a green tint to them from the protein 
production.  A master mix was made and dispensed to 20 PCR tubes that received 17.5 
µL of water, 5.5 µL of Taq buffer, 5.5 µL of dNTPs, 0.5 µL of the forward primer 404, 
0.5 µL of the reverse primer 359, and 2 µL of Taq polymerase.  Ran at the colony PCR 
settings and gel electrophoresed to determine the size of the plasmid.  
2.3.3 Fluorescence Reading of Quik-Changed royGFP 
Cultured 10 positive samples from the Quik-Changed GFPs and added 1 µL of 
Ampicillin overnight.  300 µL of the samples were added in order of the respective 
number to the 96 well plate and was read 10 times at 400 nm wavelength in the 
fluorescence reader against wildtype royGFP as a control. 
2.4 Fluorescence Reading Test 
yEGFP and royGFP colonies were taken from their respective TSA-Ampicillin 
plates and placed into a 5 mL TSB tube using a sterile toothpick and were grown 
overnight without Ampicillin.  The next day, the samples were looked at under a 
microscope to check for density, intensity of fluorescence, and amount of non-fluorescent 
cells.  Samples with higher density, fluorescence, and low amounts of non-fluorescent 
cells were selected. 
Through trial and error, it was found that by adding 10 µL of cells from the 
overnight culture to a fresh 5 mL of TSB resulted in about a 0.01 OD600 starting point.  It 
was then incubated for 2 hours to get to approximately 0.4 OD600, the Log phase of 
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bacterial growth.  As the experiment progressed, the variables were expanded upon, 
increasing the incubation time to 4-5 hours to acquire an OD600 of 0.75-0.85.  
150 µL of yEGFP and royGFP cells were placed in a 96 well plate in adjacent 
rows.  Using either hydrogen peroxide or antibiotics, the samples were serial diluted 
starting at 5% of the well and diluting down to either 10-5 or 10-9 dilution in TSB.  The 
dilutions were added in order from highest to lowest concentration after adding TSB as 
the control in the first well.  The hydrogen peroxide dilutions were pipetted into the cell 
samples and mixed thoroughly.  Testing the excitation of each well, fluorescence was 
read five times at one point in time at wavelengths 485 nm, yEGFP’s and reduced 
royGFP’s excitation, and 400 nm, oxidized royGFP’s excitation, with both having an 
emission of 525 nm.  To put the results into a readable and comparable set of numbers, 
the 400 nm reads were divided by the 485 nm readings of the same set to give a 
ratiometric value.  As royGFP is oxidized it will have more 400 nm reads increasing its 
ratiometric value showing ROS production of the stress response.  Time of test was 
increased to allow for more time for the biosensor to work.  The fluorescence was read 
every 15 or 30 minutes for 3 to 12 hours.  
2.4.1 Antibiotic Synergistic Fluorescence Test of royGFP  
Antibiotic synergistic test was conducted to determine if combining two 
antibiotics at the same time would result in an increase of ROS production.  The same 
fluorescence test as previously described was set up but with differing dilutions of 
antibiotics.  Kanamycin was tested at 5% of the well’s volume, 4.3 mM, as a control and 
0.5 % of Kanamycin, .43 mM, was mixed with a similar potency of each antibiotic, 5.3 
mM of Chloramphenicol, 14.3 mM of Ampicillin, and 0.23 mM of Norfloxacin.   
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2.4.2 Fluorescence Test of royGFP with Thiourea and DTT 
Fluorescence tests were conducted with the reducing agents thiourea and 
dithiothreitol (DTT), to support my hypothesis that ROS is actually the molecule 
oxidizing the cysteines on the royGFP biosensor.  The same fluorescence test as 
previously discussed was conducted with 75, 150, and 200 mM of DTT.  DTT was tested 
against 4.3 mM of Kanamycin and TSB alone.    








3.1 Western Blot Analysis of yEGFP 
Yeast-enhanced green fluorescent protein, yEGFP, was treated with hydrogen 
peroxide solutions as an external reactive oxygen species (ROS) source and showed no 
evidence of oligomerization in western blots as shown in figure 3-1.  Initially, the protein 
was treated for four hours in hydrogen peroxide dilutions and no oligomerization 
occurred.  With further testing, the proteins were treated for fifteen minutes and overnight 
in differing hydrogen peroxide concentrations.  The concentration of hydrogen peroxide 
and the time of treating, as well as, the amount of protein had no effect on 
oligomerization.  10 western blots were tested in this manner and in every test the GFP 





Figure 3-1: Western blot of yEGFP in an SDS-PAGE. From the left, lanes 1-4 are 
samples treated with 0, 8.7, 33.8, and 146.7 mM of hydrogen peroxide for 15 minutes. 
Lane 5 is the ladder, not seen due to not using an antibody for visualization. Lane 6 is 
DH5α, a negative control. Lanes 7-10 are samples treated with 0, 8.7, 33.8, and 146.7 
mM of hydrogen peroxide overnight. 
3.2 Quik-Change Mutagenesis of royGFP 
The Quik-Change mutagenesis to royGFP and yEGFP were successful with 
royGFP acquiring the cysteine to valine at position 48 (C48V) and yEGFP acquired 
cysteine to valine at position 70 (C70V).  Both strains grew very slowly and 
inconsistently making it difficult to find an average growth rate for fluorescence test. 
royGFP formed strands and were not brighter than the wildtype royGFP.  The mutant 
yEGFP could grow as bright as wildtype yEGFP but much less consistently.  
3.3 Fluorescence Reading Test 
3.3.1 Testing yEGFP vs royGFP in Hydrogen Peroxide 
yEGFP and royGFP were grown to 0.90 OD600 and tested in a fluorescence reader 
in differing concentrations of hydrogen peroxide diluted in water.  royGFP did not show 
any sensitivity to the hydrogen peroxide compared to its control and yEGFP as shown in 
27k Da 
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figure 3-2.  yEGFP acted as we predicted, maintaining a ratiometric value similar to its 
control.  These tests hold little value due to the royGFP control being higher than the 
hydrogen peroxide treatments.  
 
Figure 3-2: Fluorescence test of yEGFP vs royGFP in a serial dilution of hydrogen 
peroxide that is diluted in distilled water (n=1).  
 
3.3.2 Testing yEGFP vs royGFP with differing medias 
In an effort to analyze royGFP’s sensitivity to ROS, the fluorescence test was expanded 
to diluting the hydrogen peroxide in TSB media instead of water.  During this time, we 
also experimented with growing the cells to an OD600 of 0.4-0.5.  As shown in figure 3-3, 
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more similar. royGFP did not show much sensitivity but it was an improvement on the 
overall test.  
 
Figure 3-3: Fluorescence test of yEGFP vs royGFP in a serial dilution of hydrogen 
peroxide that is diluted in TSB (n=1). 
 
3.3.3 Testing yEGFP vs royGFP in the fluorescence reader overtime 
Using an external ROS source, I believed the hydrogen peroxide did not have enough 
time in the few minutes of the test to have an effect on royGFP to show sensitivity to it.  
The time of test was increased from one to two hours and the fluorescence was read in 
fifteen-minute intervals.  All other variables remained the same to determine if time is a 
factor.  The results of increasing the time showed consistent royGFP sensitivity to its 
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ratiometric values than the control and yEGFP showing sensitivity.  As shown in figure 
3-4, the 220 mM of hydrogen peroxide solution created a higher ratiometric value than 
the other dilutions and control slowly got lower.  Another improvement with time, 
allowed for the control to level out and remain lower than all of the dilutions that did 
contain ROS. 
 
Figure 3-4: Fluorescence test of royGFP over 75 minutes in a serial dilution of hydrogen 
peroxide (mM) that is diluted in TSB (n=1).  
 
3.3.4 Growing yEGFP and royGFP without Ampicillin 
Plasmids usually are maintained in cells using a nutritional or drug marker.  
Ampicillin is a common drug to maintain plasmids.  In the absence of a selectable drug 
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time.  Both yEGFP and royGFP contain an Ampicillin resistance gene that gives it a 
genetic advantage and allows us to isolate the strains when the cells are cultured.  Even 
though royGFP has started to show slight sensitivity, I believed that growing royGFP 
with Ampicillin was sensitizing it to other antibiotics.  The cells were grown on TSA-
Ampicillin plates but subsequently switched to liquid cultures and were grown without 
Ampicillin.  Figure 3-5 shows the cells grow denser and brighter after just one day and 
maintain this for a week before returning to normal.  
                          Ampicillin                                                          No Ampicillin 
Figure 3-5: royGFP cells after one day at 600X grown with Ampicillin (Left) and without 
Ampicillin (right). 
 
I repeated the fluorescence test with the cells that were grown without Ampicillin and 
increased the OD600 of the cells to 0.5 and tested it overtime.  As shown in figure 3-6, 
royGFP started showing sensitivity to the ROS from the beginning of the test and 
increased in ratiometric value over the two-hour test. As well as, more than one dilution 




Figure 3-6: Fluorescence test of royGFP that was grown without Ampicillin and read 
every fifteen minutes over two hours in a serial dilution of hydrogen peroxide (mM) 
(n=1). 
 
3.3.5 Testing yEGFP vs royGFP in Kanamycin 
After stabilizing the fluorescence test and finding the right conditions for growth 
of the cells and the time of test, I conducted fluorescence test with royGFP and yEGFP in 
differing concentrations of Kanamycin and/or Ampicillin.  Cells were grown to an OD600 
of 0.75-0.85 and the test was extended to three hours.  Increasing the time had a 
significant effect on royGFP’s sensitivity so the test was tested out to twelve hours to find 
the most optimal time point.  In figure 3-7, royGFP’s ratiometric value was higher than 
its own control and higher than the yEGFP ratiometric values in figure 3-8, indicating a 
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Figure 3-7: Fluorescence test of royGFP that was grown without Ampicillin and read 
every fifteen minutes over three hours in a serial dilution of Kanamycin (mM) (n=1). 
 
The yEGFP results showed a lower ratiometric value compared to the royGFP 
ratiometric values but was also increased over its own control. This test was repeated 
over twelve hours and had its fluorescence read every thirty minutes. The OD600 of the 
test was settled around 0.75-0.80 believing that when they were diluted in half with the 
antibiotics that they would be beginning their growth phase at 0.37-0.40 OD600.  
3.3.6 Twelve-Hour Fluorescence Test 
Over twelve hours, figure 3-8 shows that royGFP’s sensitivity gets better with 
time.  There is no significant difference between the control and the dilutions for the first 
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significant with more time with p-values of 0.024 at 6 hours and 0.00044 at 9 hours.  
Results are not shown after 9 hours due to evaporation of the liquids, concentrating the 
solution.  
 
Figure 3-8: Three-day average ratiometric value of royGFP fluorescence read over 12 
hours in Kanamycin dilutions (mM) with 95% confidence error bars and p-values 
between the control and 4.3 mM concentration (n=4). 
 
For yEGFP, the non-redox sensitive strain, a univariate test comparison between 
the control and the dilutions is not significant at any time point except for the three-hour 
time point as shown in figure 3-9. yEGFP had a difference between the control and 
dilutions but not nearly as significant as royGFP.  It also had lower ratiometric values for 
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yEGFP on the graphs results in a significant P-value at all time points.  This shows that 
with a lack of ROS, royGFP and yEGFP exhibit the same excitation and no sensitivity.  
 
Figure 3-9: Three-day average ratiometric value of yEGFP fluorescence read over 12 
hours in Kanamycin dilutions (mM) with 95% confidence error bars and p-values 
between the control and 4.3 mM concentration (n=4). 
 
Figure 3-10 shows a comparison between yEGFP and royGFP at 9 hours.  The control of 
yEGFP and royGFP act very similar and show no significant difference due to the lack of 
ROS in the control.  This is as we had hypothesized.  At the higher Kanamycin 
concentrations, 8.6 mM, 4.3 mM, and 0.86 mM, royGFP shows a significant difference 
compared to the same concentrations at yEGFP. The lower concentrations of Kanamycin 
have overlapping confidence intervals and are not significantly different showing that 
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Figure 3-10: Three test average of yEGFP vs royGFP at the nine-hour point of twelve-
hour test at the differing Kanamycin dilutions (mM) with 95% confidence error bars 
and p-values between yEGFP and royGFP at each dilution (n=4). 
  
3.3.7 Testing royGFP in Multiple Antibiotics 
After showing royGFP had consistent sensitivity and a significant difference over 
its own control and yEGFP, it was tested against Chloramphenicol, Ampicillin, 
Norfloxacin, and streptomycin to determine if it worked with multiple types of 
antibiotics.  Running a twelve-hour fluorescence test with 10%, 5%, and 1% of each 
antibiotic.  As shown in figure 3-11, 5.3 mM of Chloramphenicol triggered some ROS 
production but not to the same extent as the others.  8.6 mM of Streptomycin and 0.23 
mM of Norfloxacin were almost identical to the 4.3 mM of Kanamycin at each time 
interval, this shows that royGFP works with the same and different types of antibiotics, as 
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an Ampicillin-resistance gene.  With no triggered ROS production, royGFP shows no 
increase in ratiometric value, supporting our hypothesis that it is ROS triggered by an 
antibiotic stress response that is causing the change in excitation.   At 9 hours, TSB and 
Ampicillin are not significantly different than each other but they are both significantly 
lower than Kanamycin, Chloramphenicol, and Norfloxacin.  
 
Figure 3-11: Three test average of royGFP in 4.3 mM of Kanamycin, 5.3 mM of 
Chloramphenicol, 14.3 mM of Ampicillin, 0.23 mM of Norfloxacin, and 8.6 mM of 
Streptomycin with 95% confidence intervals (n=3). 
3.3.8 Testing yEGFP vs royGFP Fast Folders in Kanamycin 
Fast folder versions of both yEGFP and royGFP were created in our lab by Doug 
Ferrell to combat the oligomerization problem of GFP in oxidative environments.  The 



































improve the results of our fluorescence test.  As shown in figure 3-12, the fast folder 
variants acted very similar to the wildtype royGFP and yEGFP.  royGFP fast folder gets 
significantly better with time but due to low control data points, the confidence intervals 
are much wider than the royGFP wildtypes confidence intervals. royGFP was significant 
compared to its own control and yEGFP fast folder showing sensitivity to ROS with a p-
value of 0.046 at 9 hours which is less significant than the wildtype at 9 hours.  
 
 
Figure 3-12: Three-day average ratiometric value of royGFP fast folder fluorescence 
read over 9 hours in Kanamycin dilutions (mM) with 95% confidence error bars with 
p-values between the control and 4.3 mM dilutions (n=4). 
Figure 3-13 shows that yEGFP fast folder was similar to its wildtype variant but 
had an increased ratiometric value over its own control at nine hours.  The values were 
less than its royGFP fast folder and its brightness seemed to be the brightest of the four 
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Figure 3-13: Three-day average ratiometric value of yEGFP fast folder fluorescence 
read over 12 hours in Kanamycin dilutions (mM) with 95% confidence error bars 
(n=4). 
 
royGFP and royGFP fast folder had no significant difference at any time point or 
dilution.  Figure 3-14 shows that at the 9-hour point, the time of most significance, they 
are statistically the same.  The wild type royGFP on average had a slightly higher 
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Figure 3-14: Three test average ratiometric value of royGFP vs royGFP fast folder at 9 
hours in the differing Kanamycin dilutions (mM) with 95% confidence error bars and 
p-values between royGFP and royGFP FF at each dilution (n=4). 
  
3.3.9 Testing yEGFP vs royGFP in Synergistic Test 
To help combat the rise of antibiotic resistance, differing methods such as using 
multiple classes of antibiotics to attack the microbe can be a very useful tool at killing 
them before resistance can be spread.  We conducted a fluorescence test with Kanamycin, 
Ampicillin, Chloramphenicol, and Norfloxacin.  Figure 3-15 shows that there is slight 
increase in sensitivity to a Kanamycin and Ampicillin mix of 0.86 mM and 28.6 mM, 
respectively.  But there was no effect or a worse effect with the other antibiotics.  Figure 
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of the antibiotics and remained consistent throughout the control and dilutions and at a 
much lower ratiometric value than royGFP. 
 
Figure 3-15: Three test average ratiometric value of royGFP fluorescence reads in 
synergistic dilutions of 8.6 mM of Kanamycin as a control. Then Kanamycin at 0.43 
mM with 5.3 mM of Chloramphenicol, 14.3 mM of Ampicillin, and 0.23 mM of 




































































Figure 3-16: Three test average ratiometric value of yEGFP fluorescence reads in 
synergistic dilutions of 4.3 mM of Kanamycin as a control. Then Kanamycin at 0.43 
mM with 5.3 mM of Chloramphenicol, 14.3 mM of Ampicillin, and 0.23 mM of 
Norfloxacin with 95% confidence interval bars (n=3). 
 
3.3.10 Testing royGFP with DTT and Kanamycin 
royGFP was tested with TSB, 4.3 mM of Kanamycin, and 4.3 mM of Kanamycin 
with 10 mM of dithiothreitol (DTT) over one hour as shown by Figure 3-17.  There was 
no significant difference at time zero but the DTT sample was significantly lower than 
the Kanamycin alone sample with a p-value of .002 at 10 minutes and .04 at 30 minutes 


































































Figure 3-17: Three test average ratiometric value of royGFP fluorescence reads in 







































4.1 Western Blotting of yEGFP  
GFP has the ability to oligomerize in oxidative environments with its two 
naturally occurring cysteines causing a significant problem for royGFP, a biosensor 
designed to change its excitation in the presence of ROS.  Determining if GFP 
oligomerizes in the cytoplasm of bacteria is an objective in this research because this 
could be a major problem for the ultimate goal, utilizing royGFP to measure the bacterial 
ROS response to antibiotics.  GFP is a resilient protein but has been shown to 
oligomerize in oxidative environments such as the endoplasmic reticulum (19).  Multiple 
studies have attempted to overcome this problem by substituting the naturally occurring 
cysteines or increasing folding speed, which worked well at hindering oligomerization 
but requires many mutations (20).  Substituting out the cysteines has been tried and it 
hindered oligomerization but at the cost of fluorescence intensity (19).  
To determine if our GFP will oligomerize in an oxidative environment, we 
conducted western blots of yEGFP.  The results of the western blot showed that yEGFP 
placed in an oxidative environment had little to no evidence of oligomerization, whether 
the protein was treated for 15 minutes, 4 hours, or overnight, there was no evidence of 
oligomerization.  This does not support my hypothesis that oligomers would form, but 
this is a beneficial outcome.  This most likely indicates that the oxidative environment 
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would not affect royGFP due to its similar structure to yEGFP.  However, we are not sure 
the results of the western blots are reliable because there could be other issues such as the 
protein being in a low concentration to be visible in the western blot or the disulfide 
bridges being transient.  These results do line up with Aronsen et al., stating that no 
oligomers have been found in gram-negative cells like E. coli because they are difficult to 
observe (20) and due to the bacterial cytoplasm having a reducing environment.  
Regarding the western blot results, yEGFP and royGFP could still be affected by 
oligomerization altering our fluorescence test.  To resolve this, we are building on Jain et 
al. research but will take a much deeper dive and attempt to substitute the two cysteines 
with almost all of the amino acids to determine if oligomerization can be hindered 
without losing fluorescence.  If successful, it will be an important part of future GFP 
research that involves oxidative environments, allowing for reliable research without the 
worry of an affected protein due to oligomerization.  
4.2 Quik-Change Mutagenesis of royGFP 
Oligomerization of GFP in the ROS environment is still a concern due to not 
being confident in our western blot results.  Substituting in amino acids, we hypothesize 
that the right combination of amino acids in positions 48 and 70 will hinder 
oligomerization without lowering fluorescence.  Jain et al. replaced 48 and 70 for serine 
due to its similarity to cysteine in its structure.  Oligomerization was stopped but its 
fluorescence suffered significantly (19).  Hanson et al. mutated 48 and 70 with serine and 
alanine, respectively, that stopped oligomerization but alanine was deleterious to their 
fluorescence of GFP (1).  Based off of these studies, we hypothesize that hydrophobic 
and other similar amino acids such as leucine, isoleucine, methionine, valine, and 
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glutamine will be good substitutions for these two positions hopefully rendering a 
brighter biosensor that will not oligomerize.  
To begin, three mutations were created separately on royGFP.  They were 
methionine to cysteine at 48 (C48M), valine for cysteine at 48 (C48V), and glutamine for 
cysteine at 70 (C70Q) using Quik-Change Mutagenesis. Multiple colonies were 
successfully mutated and cultured with Ampicillin. Unfortunately, after being cultured 
the cells had a lack of growth and had significant fluorescence loss, going against our 
hypothesis.  There are still many more mutations and combinations to attempt and will be 
tried as this research continues. 
4.3 Fluorescence Reading Test  
4.3.1 Testing of yEGFP vs royGFP in Hydrogen Peroxide 
With the rise of antibiotic resistance, new and effective antimicrobial molecules 
are needed to fight bacterial pathogens.  Due to the low profit margin of antibiotics, 
pharmaceutical companies spend little time and effort researching new antibiotics.  To 
help combat this problem, the goal of my research is to create an efficient and cost-
effective way to determine the antibiotic activity of molecules with the royGFP biosensor 
created by Hanson et al. (1).  Most antibiotics produce an ROS response in the cell that 
royGFP is sensitive to, and this increase in ROS changes royGFP’s excitation.  
Correlating the change in excitation to the degree of ROS response can determine its 
antibiotic activity.  
To determine if royGFP is sensitive to ROS, yEGFP and royGFP were tested in 
the fluorescence reader in dilutions of hydrogen peroxide.  Initially, royGFP was not 
showing much sensitivity, going against our hypothesis. Our control values were very 
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inconsistent and even higher than the hydrogen peroxide treatment.  We began changing 
variables to find the optimal conditions for this test.  Originally, the cells were grown to 
an OD600 of 0.40, diluted the hydrogen peroxide in water, and added the dilutions to the 
wells by pipetting it on top of the cells. We switched to using TSB as the dilution media 
and began pipetting the hydrogen peroxide dilutions into the cells, mixing them better. 
TSB was a better dilatant than water, minimal media, and LB but more research can be 
done on a wider variety of media to find the most optimal media.  Both of these changes 
leveled out the control and made it more consistent but royGFP still showed little 
sensitivity.  Next, we changed the OD600 to 0.45 and began reading the fluorescence 
every 15 minutes for 2 hours because I predicted that royGFP did not have enough time 
to become oxidized to an external ROS source in so little time of the test.  We found that 
the longer the test went, the better the sensitivity to ROS there was.  After many trial and 
error runs, royGFP began to show strong and consistent sensitivity to the ROS 
environment with yEGFP as a non-sensitive baseline.  These results confirm Hanson et 
al.’s study, proving that their roGFP mutations sensitize GFP to ROS through the added 
cysteines.  This is vital to the goal of this research because it shows that royGFP can be 
expressed and functional in bacterial cells.  royGFP showed sensitivity in large amounts 
of hydrogen peroxide but it has yet to be a proven biosensor to an antibiotic ROS 
response.  The next step is to test royGFP with antibiotics that are known to trigger ROS 
responses such as Kanamycin and Ampicillin.   
4.3.2 Testing of yEGFP vs royGFP in Kanamycin 
royGFP showed sensitivity to hydrogen peroxide but has yet to be tested against 
the ROS triggered from antibiotics.  Tests were conducted against a known antibiotic, 
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Kanamycin that triggers ROS responses in E. coli. yEGFP and royGFP were tested in a 
serial dilution of Kanamycin for 2 hours and read in 15 min increments with the same 
variables as the hydrogen peroxide test, an OD600 of 0.90 and TSB media.  During these 
tests, we wanted to lower the stress on the cells as much as possible.  Both yEGFP and 
royGFP plasmids contain an Ampicillin-resistance gene so they can be isolated in culture 
and we believed growing them with Ampicillin was sensitizing them to antibiotics.  New 
cultures were taken from a TSA-Ampicillin plate but were cultured without Ampicillin. 
We hypothesized that the plasmid would be lost if not under selection after two days due 
to not needing the genetic advantage anymore but to our surprise, the two cultures grew 
denser and had brighter fluorescence for three to five days after culturing them before 
falling losing density and fluorescence.  Not only were the cells not desensitized to ROS 
making royGFP a better biosensor, but also the cells grew quicker and had a higher 
density.  This is the most surprising discovered in this research and had a strong positive 
effect on the sensitivity of royGFP, a big step forward for this research.  Using this new 
technique combined with the variables I used in the hydrogen peroxide test, royGFP 
showed strong sensitivity to Kanamycin across the two hours and was best at the end of 
the test.  Seeing that royGFP’s sensitivity to ROS increased with time, we extended the 
test to 12 hours and read the fluorescence in 30-minute intervals.  Time was shown to be 
a significant factor for royGFP sensitivity with a p-value of 0.0004 between the control 
and 4.3 mM dilution at 9 hours compared to a p-value of 0.4 at hour zero, but the dilution 
of the antibiotic was not a significant factor.  We believe time allows for the antibiotic to 
get into the cell and have an effect on its physiology and ROS production.  In addition, 
test was conducted with the cells at an OD600 of 0.375, putting them near the start of their 
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growth phase where they would be intaking a lot of nutrients, and antibiotics, from its 
environment. These results show that royGFP can be used as an effective real-time 
biosensor to measure antibiotic ROS responses.  These results are important for the 
medical field because with an efficient and cost-effective biosensor, new antibiotics can 
be found quickly to help combat bacterial pathogens.  
4.3.3 Testing of yEGFP vs royGFP Fast Folders in Kanamycin 
The fast folder mutations to GFP have been shown to hinder oligomerization and 
increase GFP’s folding ability and brightness (20).  If these fast folder mutations can be 
successfully added to our royGFP biosensor, it could allow us to not have to worry about 
the two naturally occurring cysteines that can oligomerize and can improve the efficiency 
of the biosensor.  The yEGFP and royGFP fast folder mutants were tested in the same 
fluorescence test as the wildtype variants, a twelve-hour test in dilutions of Kanamycin.  
The fast folder mutants acted very similar to his wild type variants but was not 
significantly better.  These results could mean that the oligomerization of the proteins is 
not a problem if the non-oligomerizing fast folder variant was not an improvement on the 
fluorescence test.  This strain may need its own specific environmental conditions to 
perform better than the wildtype but at the current conditions it performs the same. Due 
to its increased fluorescence and folding ability it could have a higher potential than the 
wildtype strain in differing environments and in eukaryotic cells where more proteins 
would be produced.  
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4.3.4 Testing royGFP in Antibiotic Synergistic Test 
To combat the rise of antibiotic resistance, new ways of attacking the bacteria 
need to be implemented to successfully kill the cells before a resistance gene can spread.  
Attacking with two types of antibiotics at has been a strategy to overcome resistance.  
The stronger effect can wipe out infections due to the chance of having a resistance to 
both antibiotics.   
yEGFP and royGFP were tested in the fluorescence reader in the same conditions 
as the previous test fluorescence test. The antibiotic combinations consisted of 
Kanamycin, Chloramphenicol, Streptomycin, Norfloxacin, and Ampicillin. We tested a 
1% dilution of Kanamycin mixed individually with the other four antibiotics that were 
varied from 10, 5 and 1%.  royGFP showed higher sensitivity to the combination 
Kanamycin and Ampicillin but was not significantly more effective.  In the first mix, 
royGFP showed lower sensitivity to the other antibiotics showing that they do not have 
an additive or synergistic effect.  These results show that there is no real synergistic effect 
with these antibiotics and until further combinations are tested, using multiple antibiotics 
does not increase ROS production in our E. coli strains.   The cells could be taking 
damage much quicker from the two antibiotics, dying before getting the chance to 
produce more ROS.  It is interesting that the combination that had increased sensitivity 
contained the antibiotic, Ampicillin that the GFP plasmid uses as a resistance gene.  It is 
possible that the threat of Kanamycin lowers its resistance to Ampicillin allowing for it to 
work on the cells or the energy expenditure to resist Ampicillin can be the increase in 
ROS production that is showing up on the fluorescence test. 
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4.3.5 Testing royGFP in DTT 
 To support our hypothesis that the increase in ratiometric value of royGFP is 
caused by ROS production, DTT was added to the well to counteract the ROS that was 
being produced.  DTT is dithiothreitol and acts as an ROS scavenger due to its reducing 
nature.  When added to Kanamycin, it has no effect at time zero but with time was 





CONCLUSIONS AND FUTURE WORK 
 
5.1 Conclusions 
The goal of this research was to create a cost-effective and real-time ROS 
biosensor that can measure the stress response of bacteria helping the future discovery of 
novel antibiotics.  To accomplish this, I had two main objectives; one, to determine if 
GFP oligomerization due to the two cysteines at 48 and 70 would inhibit the biosensor, 
and two, to find the optimal conditions for this biosensor to work effectively.  Through 
western blot analysis, yEGFP in an oxidative environment showed no evidence of 
oligomer formation in bacterial cytoplasm, showing it should not inhibit the biosensor.  
We substituted out the cysteines at 48 and 70 with amino acids valine, methionine, 
glutamate, and leucine but without a loss of fluorescence.  royGFP showed strong 
sensitivity to a hydrogen peroxide and antibiotically triggered ROS production with time 
being a significant factor for both royGFP and royGFP fast folder.  Time of test and 
culturing the cells without Ampicillin significantly improved the sensitivity of the 
biosensor.  The biosensor also showed strong sensitivity to multiple antibiotics but was 
not significantly better when the test were done with multiple antibiotics. royGFP proved 
to be an effective ROS biosensor with the ability to respond to the stress response of E. 
coli from antibiotics.   
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5.2 Future Work 
Future directions for this research are to further test synergistic effects of 
antibiotics, as well as switch the GFP plasmid Ampicillin resistance gene with a non-
ROS triggering antibiotic so the cells can be isolated better while still maintaining the 
fluorescence we achieved culturing them without Ampicillin.  We would like to find the 
optimal substitutions for the two naturally occurring cysteines at positions 48 and 70 with 
amino acids that will improve the fluorescence while maintaining folding ability and 
growth rate. As well as, test to determine if a royGFP superfast folder variant is sensitive 
to ROS production.  
A ROS biosensor has many capabilities and can be an effective research tool in a 
wide array of uses.  Recent studies conducted have shown that ROS plays an essential 
physiological role in cells and is not just a destructive by product of the metabolism and 
aerobic respiration.  Functions in pathways in stem cells, cancer, and the human immune 
system heavily rely on ROS as a messenger and activator to function properly.  The ROS 
biosensor can be an effective tool at determining where and at what levels these systems 
thrive and can be used to help determine therapeutic answers to problems in these areas.  
The biosensor will need to be improved upon for it to work in many different types of 
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